430 related articles for article (PubMed ID: 9524781)
21. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
Ito O; Okamoto M; Murakami Y; Nakayama R
J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
[TBL] [Abstract][Full Text] [Related]
22. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
[TBL] [Abstract][Full Text] [Related]
23. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.
Greaves SC; Gamble GD; Collins JF; Whalley GA; Sharpe DN
Am J Kidney Dis; 1994 Nov; 24(5):768-76. PubMed ID: 7977318
[TBL] [Abstract][Full Text] [Related]
24. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
Patel RK; Oliver S; Mark PB; Powell JR; McQuarrie EP; Traynor JP; Dargie HJ; Jardine AG
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
[TBL] [Abstract][Full Text] [Related]
25. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
Wanic-Kossowska M; Lehmann P; Czekalski S
Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
[TBL] [Abstract][Full Text] [Related]
26. Clinical correlates of left ventricular mass in elderly hypertensives.
James MA; Fotherby MD; Potter JF
J Hum Hypertens; 1994 Jun; 8(6):409-15. PubMed ID: 8089825
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease.
Poulikakos D; Ross L; Recio-Mayoral A; Cole D; Andoh J; Chitalia N; Sharma R; Carlos Kaski J; Banerjee D
Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):56-61. PubMed ID: 23811493
[TBL] [Abstract][Full Text] [Related]
28. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
[TBL] [Abstract][Full Text] [Related]
29. Ambulatory blood pressures and central blood pressures are associated with cardiovascular morbidity in adolescent and young adult patients receiving chronic hemodialysis.
Shah S; Swartz S; Campbell J; Srivaths PR
Pediatr Nephrol; 2019 Jul; 34(7):1261-1268. PubMed ID: 30778828
[TBL] [Abstract][Full Text] [Related]
30. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.
Yildiz A; Akkaya V; Hatemi AC; Cine N; Tükek T; Görçin B; Demirel S; Türk S; Sever MS
Nephron; 2000 Feb; 84(2):130-5. PubMed ID: 10657713
[TBL] [Abstract][Full Text] [Related]
31. [Left ventricular hypertrophy in patient on dialysis].
Lovcić V; Sebetić D; Klobucić M; Kusec V
Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
[TBL] [Abstract][Full Text] [Related]
32. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.
Suzuki H; Nakamoto H; Okada H; Sugahara S; Kanno Y
Adv Perit Dial; 2003; 19():59-66. PubMed ID: 14763035
[TBL] [Abstract][Full Text] [Related]
33. Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.
Jaques DA; Müller H; Martinez C; De Seigneux S; Martin PY; Ponte B; Saudan P
Blood Press Monit; 2018 Oct; 23(5):244-252. PubMed ID: 29958233
[TBL] [Abstract][Full Text] [Related]
34. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
[TBL] [Abstract][Full Text] [Related]
35. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
[TBL] [Abstract][Full Text] [Related]
36. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis.
Moriya H; Ohtake T; Kobayashi S
Nephrol Dial Transplant; 2007 Apr; 22(4):1198-204. PubMed ID: 17255132
[TBL] [Abstract][Full Text] [Related]
37. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
38. Blood Pressure Measurement and Left Ventricular Mass Index in Hemodialysis Patients: Comparison of Several Methods.
Nassiri AA; Lotfollahi L; Behzadnia N; Alavi Darazam I; Hakemi MS; Rahimzadeh Kalaleh A; Kamalkhani M
Iran J Kidney Dis; 2018 May; 12(3):185-189. PubMed ID: 29891749
[TBL] [Abstract][Full Text] [Related]
39. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
[TBL] [Abstract][Full Text] [Related]
40. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients.
Weinreich T; De los Ríos T; Gauly A; Passlick-Deetjen J
Clin Nephrol; 2006 Dec; 66(6):433-9. PubMed ID: 17176915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
